BioSpace News Archive

Kahn Swick & Foti, LLC and Charles C. Foti, Jr., remind investors that they have until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Allergan plc. (NYSE: AGN), if they purchased the Company’s shares between February 24, 2017, and December 19, 2018

Wounded Warrior Project® (WWP) announced support for Vail Veterans Program (VVP), a 501(c)(3) organization that rebuilds veterans’ confidence through extraordinary, therapeutic experiences.

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported new findings identifying a potential association between CXCL12 expression and clinical benefit in patients with pancreatic cancer treated with tipifarnib.

Starling Brands is pleased to announce the expansion of their global licensing, manufacturing and distribution deal with world-renowned brand Jayden’s Juice, one of the pioneers in the cannabis CBD movement.

Bayer Animal Health announces the launch of Coraxis™ (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs.

Support for outstanding high school seniors pursuing water, wastewater careers

International Brotherhood of Teamsters General President Jim Hoffa has appointed Nina Bugbee as director of the newly created Teamsters Health Care Division and director of the Women’s Conference.

Regeneron Pharmaceuticals, Inc. announced that it will report its fourth quarter and full year 2018 financial and operating results on Wednesday, February 6, 2019, before the U.S. financial markets open.

Swisse Wellness, Australia’s No.1 Brand in Vitamins and Supplements, announces a global partnership with international actor Chris Hemsworth as its newest Global Brand Ambassador.

Cronos Group Inc. is pleased to announce that the meeting materials for a special meeting of holders of common shares of the Company to be held on February 21, 2019, including the management proxy circular dated December 31, 2018, prepared in connection with the proposed C$2.4 billion equity investment by Altria Group, Inc. in Cronos Group previously announced on December 7, 2018, have been mailed to Shareholders and filed with the relevant Canadian securities regulators.